
Albertsons Companies (ACI) Stock Forecast & Price Target
Albertsons Companies (ACI) Analyst Ratings
Bulls say
Albertsons Companies has demonstrated steady growth, with net sales revenue increasing by 2.08% year-over-year, from $79.71 billion to $81.37 billion for the 12 months ending August 2025. The company's pharmacy segment showed significant strength, reporting a 19% year-over-year increase in sales due to higher prescription volumes and demand for GLP-1 treatments, which complements its overall resilient performance across grocery and digital retail channels. Additionally, digital sales surged by 21% year-over-year, contributing to an e-commerce penetration of approximately 9.5% of total grocery sales, underscoring Albertsons' capacity for customer engagement and operational efficiency.
Bears say
Albertsons Companies has experienced a significant decline in key financial metrics, including a 50 basis point drop in gross margin to 27.4%, primarily driven by a shift towards lower-margin pharmacy and digital segments. The company's Net Operating Profit After Tax (NOPAT) decreased 3.53% year-over-year, and Economic Operating Cash Flow (EBITDAR) fell by 2.33%, indicating ongoing challenges in maintaining profitability. Additionally, the Return on Capital (ROC) and Economic Profit (EP) also showed declines, further highlighting the adverse impact of increased costs in digital fulfillment and strategic investments on overall financial health.
This aggregate rating is based on analysts' research of Albertsons Companies and is not a guaranteed prediction by Public.com or investment advice.
Albertsons Companies (ACI) Analyst Forecast & Price Prediction
Start investing in Albertsons Companies (ACI)
Order type
Buy in
Order amount
Est. shares
0 shares